Emergent dolutegravir resistance in integrase-naïve, treatment experienced patients from Zimbabwe

We report two cases of dolutegravir (DTG) resistance in highly treatment experienced patients. Monitoring for treatment failure and adherence support is important in highly treatment experienced patients taking DTG. What this study adds: Dolutegravir is the mainstay of HIV treatment programmes and...

Full description

Bibliographic Details
Main Authors: Linda A. Mandikiyana Chirimuta, Margaret J. Pascoe, Sara Lowe
Format: Article
Language:English
Published: AOSIS 2022-10-01
Series:Southern African Journal of HIV Medicine
Subjects:
Online Access:https://sajhivmed.org.za/index.php/hivmed/article/view/1435
_version_ 1811193324468436992
author Linda A. Mandikiyana Chirimuta
Margaret J. Pascoe
Sara Lowe
author_facet Linda A. Mandikiyana Chirimuta
Margaret J. Pascoe
Sara Lowe
author_sort Linda A. Mandikiyana Chirimuta
collection DOAJ
description We report two cases of dolutegravir (DTG) resistance in highly treatment experienced patients. Monitoring for treatment failure and adherence support is important in highly treatment experienced patients taking DTG. What this study adds: Dolutegravir is the mainstay of HIV treatment programmes and emergence of drug resistance to DTG is of public health relevance.
first_indexed 2024-04-12T00:06:32Z
format Article
id doaj.art-a2309c1898e44e92a323dcf9b3467cc5
institution Directory Open Access Journal
issn 1608-9693
2078-6751
language English
last_indexed 2024-04-12T00:06:32Z
publishDate 2022-10-01
publisher AOSIS
record_format Article
series Southern African Journal of HIV Medicine
spelling doaj.art-a2309c1898e44e92a323dcf9b3467cc52022-12-22T03:56:05ZengAOSISSouthern African Journal of HIV Medicine1608-96932078-67512022-10-01231e1e310.4102/sajhivmed.v23i1.1435813Emergent dolutegravir resistance in integrase-naïve, treatment experienced patients from ZimbabweLinda A. Mandikiyana Chirimuta0Margaret J. Pascoe1Sara Lowe2Newlands Clinic, Ruedi Luethy Foundation, HarareNewlands Clinic, Ruedi Luethy Foundation, HarareNewlands Clinic, Ruedi Luethy Foundation, HarareWe report two cases of dolutegravir (DTG) resistance in highly treatment experienced patients. Monitoring for treatment failure and adherence support is important in highly treatment experienced patients taking DTG. What this study adds: Dolutegravir is the mainstay of HIV treatment programmes and emergence of drug resistance to DTG is of public health relevance.https://sajhivmed.org.za/index.php/hivmed/article/view/1435hiv drug resistancedolutegravirintegrase strand inhibitorantiretroviral treatmenthiv
spellingShingle Linda A. Mandikiyana Chirimuta
Margaret J. Pascoe
Sara Lowe
Emergent dolutegravir resistance in integrase-naïve, treatment experienced patients from Zimbabwe
Southern African Journal of HIV Medicine
hiv drug resistance
dolutegravir
integrase strand inhibitor
antiretroviral treatment
hiv
title Emergent dolutegravir resistance in integrase-naïve, treatment experienced patients from Zimbabwe
title_full Emergent dolutegravir resistance in integrase-naïve, treatment experienced patients from Zimbabwe
title_fullStr Emergent dolutegravir resistance in integrase-naïve, treatment experienced patients from Zimbabwe
title_full_unstemmed Emergent dolutegravir resistance in integrase-naïve, treatment experienced patients from Zimbabwe
title_short Emergent dolutegravir resistance in integrase-naïve, treatment experienced patients from Zimbabwe
title_sort emergent dolutegravir resistance in integrase naive treatment experienced patients from zimbabwe
topic hiv drug resistance
dolutegravir
integrase strand inhibitor
antiretroviral treatment
hiv
url https://sajhivmed.org.za/index.php/hivmed/article/view/1435
work_keys_str_mv AT lindaamandikiyanachirimuta emergentdolutegravirresistanceinintegrasenaivetreatmentexperiencedpatientsfromzimbabwe
AT margaretjpascoe emergentdolutegravirresistanceinintegrasenaivetreatmentexperiencedpatientsfromzimbabwe
AT saralowe emergentdolutegravirresistanceinintegrasenaivetreatmentexperiencedpatientsfromzimbabwe